The Business Research Company’s 2026 market reports include new capabilities such as market attractiveness scoring and analysis, total addressable market analysis, company scoring matrix, interactive excel data dashboard, improved supply chain analysis, upcoming startups in the market, and overview of key products, aimed at improving the depth, usability, and strategic value of the insights delivered.
How Much Is The Molecular Diagnostics Devices And Equipment Market Expected To Grow In Terms Of Market Value Between 2026 And 2030?
The molecular diagnostics devices and equipment market size has experienced significant expansion in recent years. It is projected to increase from $27.23 billion in 2025 to $30.33 billion in 2026, reflecting a compound annual growth rate (CAGR) of 11.4%. The market’s historical growth can be attributed to growth in infectious disease testing, expansion of genetic screening programs, rising use of molecular diagnostics in oncology, improvements in sequencing accuracy, and increased clinical awareness of molecular testing.
The molecular diagnostics devices and equipment market is projected to experience swift expansion in the coming years. It will grow to $48.84 billion in 2030 at a compound annual growth rate (CAGR) of 12.7%. This anticipated growth during the forecast period can be attributed to factors such as an escalating demand for personalized medicine, greater investments in genomic diagnostics, the broadening scope of decentralized molecular testing, the increasing integration of automated sample processing, and a heightened emphasis on detecting diseases at an early stage. Key trends for the forecast period encompass a wider embrace of PCR-based testing platforms, an increase in the utilization of next-generation sequencing technologies, the expanding incorporation of diagnostic software and bioinformatics, the broadening of companion diagnostics applications, and an intensified focus on early and personalized diagnoses.
Download the Free Sample Report to Explore Key Market Insights:
https://www.thebusinessresearchcompany.com/sample.aspx?id=2595&type=smp
Which Growth Drivers Are Contributing To The Progress Of The Molecular Diagnostics Devices And Equipment Market?
The escalating occurrence of infectious diseases is set to drive the expansion of the molecular diagnostic devices and equipment market moving forward. These illnesses are defined as conditions caused by pathogenic microorganisms, such as bacteria, viruses, fungi, or parasites, which possess the ability to transfer between individuals or from animals to humans. Factors such as antimicrobial resistance, increased globalization and travel, urbanization, socioeconomic disparities, and an aging population are contributing to this rise in infectious disease incidence. Molecular diagnostic devices and equipment serve as crucial tools in both the detection and management of these diseases. For example, according to the Centers for Disease Control and Prevention, a US-based government agency, the volume of tuberculosis cases increased from 8,320 in 2022 to 9,615 in 2023, representing an increment of 1,295 cases. Moreover, the incidence rate rose from 2.5 per 100,000 individuals in 2022 to 2.9 in 2023. This upward trend in infectious disease cases is thus propelling the growth of the molecular diagnostic devices and equipment market.
What Major Segment Divisions Exist Within The Molecular Diagnostics Devices And Equipment Market?
The molecular diagnostics devices and equipment market covered in this report is segmented –
1) By Product: Instruments, Reagents And Consumables, Software
2) By Technology: DNA(Deoxyribonucleic acid) sequencing, Polymerase chain reaction, Isothermal Nucleic Acid Amplification Technology, Transcription Mediated Amplification (TMA), In situ hybridization, Microarrays, Mass spectrometry, Other Technologies
3) By Application: Cancer, Pharmacogenomics, Genetic testing, Infectious disease, Prenatal, Other Applications
4) By End User: Diagnostic laboratories, Hospitals, Other End Users
Subsegments:
1) By Instruments: Polymerase Chain Reaction (PCR) Machines, Nucleic Acid Analyzers, DNA Sequencers, Microarrays
2) By Reagents And Consumables: PCR Reagents, DNA Probes And Primers, Sample Preparation Kits, Control And Calibration Materials
3) By Software: Data Analysis Software, Laboratory Information Management Systems (LIMS), Bioinformatics Software, Integration Software For Instrumentation
How Are Trends Shaping The Direction Of The Molecular Diagnostics Devices And Equipment Market?
Leading firms within the molecular diagnostics devices and equipment market are creating advanced products, specifically high-throughput sample-to-result instruments for molecular diagnostics. These high-throughput systems will utilize ELITech’s established extraction and assay technology and be compatible with the reagents used by InGenius and BeGenius. An example of this is ELITechGroup, a France-based integrated in-vitro diagnostics company, which introduced a high-throughput sample-to-result instrument for molecular diagnostics in April 2023. This device allows for ongoing loading of samples and reagents along with true random-access functionality. Users will have the flexibility to simultaneously execute various PCR reagents, protocols, and sample matrices.
Which Companies Are Leading Innovation In The Molecular Diagnostics Devices And Equipment Market?
Major companies operating in the molecular diagnostics devices and equipment market are F. Hoffmann-La Roche Ltd, QIAGEN N.V., Abbott Laboratories, Danaher Corporation, Biomérieux, Becton Dickinson & Co, Siemens Healthineers AG, Grifols S.A., Sysmex Corporation, Abbott India Limited, Qiagen India Pvt Ltd, Biocartis, Bio-Techne India Private Limited, Cleaver Scientific, Zhejiang Di’an Diagnostics Technology Co. Ltd, Kindstar Global, BGI-Shenzhen, OriGene Technologies, Nippon Becton Dickinson Company, QuantuMDx, Yourgene Health, Genefirst, TestLine, Hologic Inc., Illumina Inc., Cepheid Inc., Agilent Technologies Inc., AutoGenomics, Bio-Rad Laboratories Inc, Ortho Clinical Diagnostics Inc, Sysmex Middle East FZ-LLC, QIAGEN SA (Pty) Ltd
Read the full molecular diagnostics devices and equipment market report here:
What Are The Leading Geographic Regions In The Molecular Diagnostics Devices And Equipment Market?
Asia-Pacific was the largest region in the global molecular diagnostics devices (or) equipment market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the molecular diagnostics devices and equipment market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Request A Tailored Molecular Diagnostics Devices And Equipment Market Research Report For Competitive Advantage:
https://www.thebusinessresearchcompany.com/customise?id=2595&type=smp
Browse Through More Reports Similar to the Global Molecular Diagnostics Devices And Equipment Market 2026, By The Business Research Company
Dental Diagnostic Imaging Devices And Equipment Market Report 2026
Point Of Care Molecular Diagnostics Market Report 2026
Microbiology Diagnostic Devices And Equipment Market Report 2026
Get in touch with us:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas +1 310-496-7795
Asia +44 7882 955267 & +91 8897263534
Europe +44 7882 955267
Email us at info@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model